Morgan Stanley Raises Cerebras Systems Price Target to $273
Morgan Stanley raised its price target on Cerebras Systems Inc. (NASDAQ:CBRS) to $273 from $250, keeping an Overweight rating, following the release of strong fiscal Q1 2026 results.
Key Numbers
Morgan Stanley raised its price target on Cerebras Systems Inc. (NASDAQ:CBRS) to $273 from $250, maintaining an Overweight rating, on June 24, 2026. The revision comes after the company reported strong fiscal Q1 2026 results.
Rating Change
- Before: Price target $250, Overweight rating.
- After: Price target $273, Overweight rating.
Analyst Rationale
The Morgan Stanley analyst believes Cerebras Systems' Q1 2026 results exceeded expectations, boosting confidence in the company's growth prospects in the AI chip market. Strong demand for Cerebras' solutions, particularly for large language model training, was cited as a key driver.
Context
Cerebras Systems is a promising player in the AI chip space, drawing increased analyst attention since its IPO. Current coverage includes several investment banks with ratings ranging from Buy to Hold, and price targets between $200 and $300.
Conclusion
Morgan Stanley's price target hike reflects cautious optimism about Cerebras Systems' future. However, investors should consider the high volatility in the tech sector and intense competition from giants like NVIDIA.
Frequently Asked Questions
Found this useful? Share it